1. Home
  2. RNST vs NVAX Comparison

RNST vs NVAX Comparison

Compare RNST & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$35.18

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.64

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
NVAX
Founded
1904
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
RNST
NVAX
Price
$35.18
$6.64
Analyst Decision
Strong Buy
Hold
Analyst Count
6
8
Target Price
$43.17
$9.75
AVG Volume (30 Days)
529.0K
3.2M
Earning Date
01-27-2026
11-06-2025
Dividend Yield
2.59%
N/A
EPS Growth
N/A
N/A
EPS
1.84
2.07
Revenue
$775,309,000.00
$1,064,651,000.00
Revenue This Year
$43.37
$58.91
Revenue Next Year
$13.13
N/A
P/E Ratio
$19.33
$3.25
Revenue Growth
13.04
20.27
52 Week Low
$26.97
$5.01
52 Week High
$40.40
$11.55

Technical Indicators

Market Signals
Indicator
RNST
NVAX
Relative Strength Index (RSI) 39.53 42.77
Support Level $36.84 $6.36
Resistance Level $36.33 $7.00
Average True Range (ATR) 0.55 0.20
MACD -0.23 0.04
Stochastic Oscillator 3.77 42.97

Price Performance

Historical Comparison
RNST
NVAX

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: